Coronavirus Test Kits Market in Europe 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	147 Pages	TechNavio	October, 2023	INF18215923

Best Price Guarantee
Price	from $2,500
Length	147 Pages
Publisher	TechNavio
Published Date	October, 2023
SKU	INF18215923

Test Kits Market In Europe 2023-2027

The test kits market in Europe is forecasted to grow by USD -17.29 bn during 2022-2027, decelerating at a CAGR of -23.8% during the forecast period. The report on the test kits market in Europe provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing government funding, rising focus on preventing the spread of COVID-19 pandemic, and increasing number of strategic alliances.

Technavio's test kits market in Europe is segmented as below:

By End-user

Government
Non-government

By Type

Rapid test kit
RT-PCR
Others

This study identifies the advent of SARS-CoV-2 mutation as one of the prime reasons driving the test kits market in Europe growth during the next few years. Also, increasing demand for point-of-care diagnostics and rising adoption of rapid diagnostic products will lead to sizable demand in the market.

The report on the test kits market in Europe covers the following areas:

Test kits market in Europe sizing
Test kits market in Europe forecast
Test kits market in Europe industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading test kits market in Europe vendors that include 3D Biomedicine Science and Technology Co. Ltd., Abbott Laboratories, altona Diagnostics GmbH, BGI Genomics Co. Ltd., Bio Rad Laboratories Inc., bioMerieux SA, BIOSYNEX SA, Bruker Corp., Co Diagnostics Inc., Danaher Corp., Edinburgh Genetics Ltd., F. Hoffmann La Roche Ltd., MultiplexDX, PerkinElmer Inc., QIAGEN NV, Robert Bosch GmbH, Sd Biosensor Inc., Seegene Inc., Thermo Fisher Scientific Inc., and ZEKMED. Also, the test kits market in Europe analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary €“ Chart on Market Overview; Exhibit 02: Executive Summary €“ Data Table on Market Overview; Exhibit 03: Executive Summary €“ Chart on Country Market Characteristics; Exhibit 04: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibit 05: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibit 06: Executive Summary €“ Chart on Market Segmentation by Type; Exhibit 07: Executive Summary €“ Chart on Incremental Growth; Exhibit 08: Executive Summary €“ Data Table on Incremental Growth; Exhibit 09: Executive Summary €“ Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 10: Parent market; Exhibit 11: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 12: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 13: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 14: Chart on Europe - Market size and forecast 2022-2027 ($ billion); Exhibit 15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibit 16: Chart on Europe: Year-over-year growth 2022-2027 (%); Exhibit 17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion)
4 Five Forces Analysis: 4.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 4.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; 4.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; 4.4 Threat of new entrants; Exhibit 21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; 4.5 Threat of substitutes; Exhibit 22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; 4.6 Threat of rivalry; Exhibit 23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; 4.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
5 Market Segmentation by End-user: 5.1 Market segments; Exhibit 25: Chart on End-user - Market share 2022-2027 (%); Exhibit 26: Data Table on End-user - Market share 2022-2027 (%); 5.2 Comparison by End-user; Exhibit 27: Chart on Comparison by End-user; Exhibit 28: Data Table on Comparison by End-user; 5.3 Government - Market size and forecast 2022-2027; Exhibit 29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibit 31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on Government - Year-over-year growth 2022-2027 (%); 5.4 Non-government - Market size and forecast 2022-2027; Exhibit 33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibit 35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); 5.5 Market opportunity by End-user; Exhibit 37: Market opportunity by End-user ($ billion); Exhibit 38: Data Table on Market opportunity by End-user ($ billion)
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 39: Chart on Type - Market share 2022-2027 (%); Exhibit 40: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 41: Chart on Comparison by Type; Exhibit 42: Data Table on Comparison by Type; 6.3 Rapid test kit - Market size and forecast 2022-2027; Exhibit 43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibit 45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); 6.4 RT-PCR - Market size and forecast 2022-2027; Exhibit 47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibit 49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); 6.5 Others - Market size and forecast 2022-2027; Exhibit 51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Others - Year-over-year growth 2022-2027 (%); 6.6 Market opportunity by Type; Exhibit 55: Market opportunity by Type ($ billion); Exhibit 56: Data Table on Market opportunity by Type ($ billion)
7 Customer Landscape: 7.1 Customer landscape overview; Exhibit 57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
8 Geographic Landscape: 8.1 Geographic segmentation; Exhibit 58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibit 59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); 8.2 Geographic comparison; Exhibit 60: Chart on Geographic comparison; Exhibit 61: Data Table on Geographic comparison; 8.3 UK - Market size and forecast 2022-2027; Exhibit 62: Chart on UK - Market size and forecast 2022-2027 ($ billion); Exhibit 63: Data Table on UK - Market size and forecast 2022-2027 ($ billion); Exhibit 64: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibit 65: Data Table on UK - Year-over-year growth 2022-2027 (%); 8.4 Spain - Market size and forecast 2022-2027; Exhibit 66: Chart on Spain - Market size and forecast 2022-2027 ($ billion); Exhibit 67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion); Exhibit 68: Chart on Spain - Year-over-year growth 2022-2027 (%); Exhibit 69: Data Table on Spain - Year-over-year growth 2022-2027 (%); 8.5 Russia - Market size and forecast 2022-2027; Exhibit 70: Chart on Russia - Market size and forecast 2022-2027 ($ billion); Exhibit 71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion); Exhibit 72: Chart on Russia - Year-over-year growth 2022-2027 (%); Exhibit 73: Data Table on Russia - Year-over-year growth 2022-2027 (%); 8.6 France - Market size and forecast 2022-2027; Exhibit 74: Chart on France - Market size and forecast 2022-2027 ($ billion); Exhibit 75: Data Table on France - Market size and forecast 2022-2027 ($ billion); Exhibit 76: Chart on France - Year-over-year growth 2022-2027 (%); Exhibit 77: Data Table on France - Year-over-year growth 2022-2027 (%); 8.7 Rest of Europe - Market size and forecast 2022-2027; Exhibit 78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion); Exhibit 79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion); Exhibit 80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibit 81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%); 8.8 Market opportunity By Geographical Landscape; Exhibit 82: Market opportunity By Geographical Landscape ($ billion); Exhibit 83: Data Table on Market opportunity By Geographical Landscape ($ billion)
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 84: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 85: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 86: Overview on factors of disruption; 10.4 Industry risks; Exhibit 87: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 88: Vendors covered; 11.2 Market positioning of vendors; Exhibit 89: Matrix on vendor position and classification; 11.3 3D Biomedicine Science and Technology Co. Ltd.; Exhibit 90: 3D Biomedicine Science and Technology Co. Ltd. - Overview; Exhibit 91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; Exhibit 92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; 11.4 Abbott Laboratories; Exhibit 93: Abbott Laboratories - Overview; Exhibit 94: Abbott Laboratories - Business segments; Exhibit 95: Abbott Laboratories - Key news; Exhibit 96: Abbott Laboratories - Key offerings; Exhibit 97: Abbott Laboratories - Segment focus; 11.5 altona Diagnostics GmbH; Exhibit 98: altona Diagnostics GmbH - Overview; Exhibit 99: altona Diagnostics GmbH - Product / Service; Exhibit 100: altona Diagnostics GmbH - Key offerings; 11.6 BGI Genomics Co. Ltd.; Exhibit 101: BGI Genomics Co. Ltd. - Overview; Exhibit 102: BGI Genomics Co. Ltd. - Product / Service; Exhibit 103: BGI Genomics Co. Ltd. - Key offerings; 11.7 Bio Rad Laboratories Inc.; Exhibit 104: Bio Rad Laboratories Inc. - Overview; Exhibit 105: Bio Rad Laboratories Inc. - Business segments; Exhibit 106: Bio Rad Laboratories Inc. - Key news; Exhibit 107: Bio Rad Laboratories Inc. - Key offerings; Exhibit 108: Bio Rad Laboratories Inc. - Segment focus; 11.8 bioMerieux SA; Exhibit 109: bioMerieux SA - Overview; Exhibit 110: bioMerieux SA - Product / Service; Exhibit 111: bioMerieux SA - Key offerings; 11.9 BIOSYNEX SA; Exhibit 112: BIOSYNEX SA - Overview; Exhibit 113: BIOSYNEX SA - Product / Service; Exhibit 114: BIOSYNEX SA - Key offerings; 11.10 Bruker Corp.; Exhibit 115: Bruker Corp. - Overview; Exhibit 116: Bruker Corp. - Business segments; Exhibit 117: Bruker Corp. - Key news; Exhibit 118: Bruker Corp. - Key offerings; Exhibit 119: Bruker Corp. - Segment focus; 11.11 Co Diagnostics Inc.; Exhibit 120: Co Diagnostics Inc. - Overview; Exhibit 121: Co Diagnostics Inc. - Product / Service; Exhibit 122: Co Diagnostics Inc. - Key news; Exhibit 123: Co Diagnostics Inc. - Key offerings; 11.12 Danaher Corp.; Exhibit 124: Danaher Corp. - Overview; Exhibit 125: Danaher Corp. - Business segments; Exhibit 126: Danaher Corp. - Key news; Exhibit 127: Danaher Corp. - Key offerings; Exhibit 128: Danaher Corp. - Segment focus; 11.13 Edinburgh Genetics Ltd.; Exhibit 129: Edinburgh Genetics Ltd. - Overview; Exhibit 130: Edinburgh Genetics Ltd. - Product / Service; Exhibit 131: Edinburgh Genetics Ltd. - Key offerings; 11.14 F. Hoffmann La Roche Ltd.; Exhibit 132: F. Hoffmann La Roche Ltd. - Overview; Exhibit 133: F. Hoffmann La Roche Ltd. - Business segments; Exhibit 134: F. Hoffmann La Roche Ltd. - Key news; Exhibit 135: F. Hoffmann La Roche Ltd. - Key offerings; Exhibit 136: F. Hoffmann La Roche Ltd. - Segment focus; 11.15 QIAGEN NV; Exhibit 137: QIAGEN NV - Overview; Exhibit 138: QIAGEN NV - Product / Service; Exhibit 139: QIAGEN NV - Key news; Exhibit 140: QIAGEN NV - Key offerings; 11.16 Thermo Fisher Scientific Inc.; Exhibit 141: Thermo Fisher Scientific Inc. - Overview; Exhibit 142: Thermo Fisher Scientific Inc. - Business segments; Exhibit 143: Thermo Fisher Scientific Inc. - Key news; Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus; 11.17 ZEKMED; Exhibit 146: ZEKMED - Overview; Exhibit 147: ZEKMED - Product / Service; Exhibit 148: ZEKMED - Key offerings
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 149: Inclusions checklist; Exhibit 150: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 151: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 152: Research methodology; Exhibit 153: Validation techniques employed for market sizing; Exhibit 154: Information sources; 12.5 List of abbreviations; Exhibit 155: List of abbreviations; generated by emerging segments in healthcare: Growing adoption of healthcare supplies for home-based healthcare, home medical devices, and other advanced application areas such as robotic surgery will aid in the growth of this market.; Exhibits:; Exhibits1: Executive Summary €“ Chart on Market Overview; Exhibits2: Executive Summary €“ Data Table on Market Overview; Exhibits3: Executive Summary €“ Chart on Country Market Characteristics; Exhibits4: Executive Summary €“ Chart on Market By Geographical Landscape; Exhibits5: Executive Summary €“ Chart on Market Segmentation by End-user; Exhibits6: Executive Summary €“ Chart on Market Segmentation by Type; Exhibits7: Executive Summary €“ Chart on Incremental Growth; Exhibits8: Executive Summary €“ Data Table on Incremental Growth; Exhibits9: Executive Summary €“ Chart on Vendor Market Positioning; Exhibits10: Parent market; Exhibits11: Market Characteristics; Exhibits12: Offerings of vendors included in the market definition; Exhibits13: Market segments; Exhibits14: Chart on Europe - Market size and forecast 2022-2027 ($ billion); Exhibits15: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits16: Chart on Europe: Year-over-year growth 2022-2027 (%); Exhibits17: Data Table on Regional - Market size and forecast 2022-2027 ($ billion); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers €“ Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers €“ Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants €“ Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes €“ Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry €“ Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on End-user - Market share 2022-2027 (%); Exhibits26: Data Table on End-user - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by End-user; Exhibits28: Data Table on Comparison by End-user; Exhibits29: Chart on Government - Market size and forecast 2022-2027 ($ billion); Exhibits30: Data Table on Government - Market size and forecast 2022-2027 ($ billion); Exhibits31: Chart on Government - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on Government - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits34: Data Table on Non-government - Market size and forecast 2022-2027 ($ billion); Exhibits35: Chart on Non-government - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Non-government - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by End-user ($ billion); Exhibits38: Data Table on Market opportunity by End-user ($ billion); Exhibits39: Chart on Type - Market share 2022-2027 (%); Exhibits40: Data Table on Type - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by Type; Exhibits42: Data Table on Comparison by Type; Exhibits43: Chart on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits44: Data Table on Rapid test kit - Market size and forecast 2022-2027 ($ billion); Exhibits45: Chart on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Rapid test kit - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits48: Data Table on RT-PCR - Market size and forecast 2022-2027 ($ billion); Exhibits49: Chart on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on RT-PCR - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibits52: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibits53: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits55: Market opportunity by Type ($ billion); Exhibits56: Data Table on Market opportunity by Type ($ billion); Exhibits57: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits58: Chart on Market share By Geographical Landscape - 2022-2027 (%); Exhibits59: Data Table on Market share By Geographical Landscape - 2022-2027 (%); Exhibits60: Chart on Geographic comparison; Exhibits61: Data Table on Geographic comparison; Exhibits62: Chart on UK - Market size and forecast 2022-2027 ($ billion); Exhibits63: Data Table on UK - Market size and forecast 2022-2027 ($ billion); Exhibits64: Chart on UK - Year-over-year growth 2022-2027 (%); Exhibits65: Data Table on UK - Year-over-year growth 2022-2027 (%); Exhibits66: Chart on Spain - Market size and forecast 2022-2027 ($ billion); Exhibits67: Data Table on Spain - Market size and forecast 2022-2027 ($ billion); Exhibits68: Chart on Spain - Year-over-year growth 2022-2027 (%); Exhibits69: Data Table on Spain - Year-over-year growth 2022-2027 (%); Exhibits70: Chart on Russia - Market size and forecast 2022-2027 ($ billion); Exhibits71: Data Table on Russia - Market size and forecast 2022-2027 ($ billion); Exhibits72: Chart on Russia - Year-over-year growth 2022-2027 (%); Exhibits73: Data Table on Russia - Year-over-year growth 2022-2027 (%); Exhibits74: Chart on France - Market size and forecast 2022-2027 ($ billion); Exhibits75: Data Table on France - Market size and forecast 2022-2027 ($ billion); Exhibits76: Chart on France - Year-over-year growth 2022-2027 (%); Exhibits77: Data Table on France - Year-over-year growth 2022-2027 (%); Exhibits78: Chart on Rest of Europe - Market size and forecast 2022-2027 ($ billion); Exhibits79: Data Table on Rest of Europe - Market size and forecast 2022-2027 ($ billion); Exhibits80: Chart on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibits81: Data Table on Rest of Europe - Year-over-year growth 2022-2027 (%); Exhibits82: Market opportunity By Geographical Landscape ($ billion); Exhibits83: Data Table on Market opportunity By Geographical Landscape ($ billion); Exhibits84: Impact of drivers and challenges in 2022 and 2027; Exhibits85: Overview on Criticality of inputs and Factors of differentiation; Exhibits86: Overview on factors of disruption; Exhibits87: Impact of key risks on business; Exhibits88: Vendors covered; Exhibits89: Matrix on vendor position and classification; Exhibits90: 3D Biomedicine Science and Technology Co. Ltd. - Overview; Exhibits91: 3D Biomedicine Science and Technology Co. Ltd. - Product / Service; Exhibits92: 3D Biomedicine Science and Technology Co. Ltd. - Key offerings; Exhibits93: Abbott Laboratories - Overview; Exhibits94: Abbott Laboratories - Business segments; Exhibits95: Abbott Laboratories - Key news; Exhibits96: Abbott Laboratories - Key offerings; Exhibits97: Abbott Laboratories - Segment focus; Exhibits98: altona Diagnostics GmbH - Overview; Exhibits99: altona Diagnostics GmbH - Product / Service; Exhibits100: altona Diagnostics GmbH - Key offerings; Exhibits101: BGI Genomics Co. Ltd. - Overview; Exhibits102: BGI Genomics Co. Ltd. - Product / Service; Exhibits103: BGI Genomics Co. Ltd. - Key offerings; Exhibits104: Bio Rad Laboratories Inc. - Overview; Exhibits105: Bio Rad Laboratories Inc. - Business segments; Exhibits106: Bio Rad Laboratories Inc. - Key news; Exhibits107: Bio Rad Laboratories Inc. - Key offerings; Exhibits108: Bio Rad Laboratories Inc. - Segment focus; Exhibits109: bioMerieux SA - Overview; Exhibits110: bioMerieux SA - Product / Service; Exhibits111: bioMerieux SA - Key offerings; Exhibits112: BIOSYNEX SA - Overview; Exhibits113: BIOSYNEX SA - Product / Service; Exhibits114: BIOSYNEX SA - Key offerings; Exhibits115: Bruker Corp. - Overview; Exhibits116: Bruker Corp. - Business segments; Exhibits117: Bruker Corp. - Key news; Exhibits118: Bruker Corp. - Key offerings; Exhibits119: Bruker Corp. - Segment focus; Exhibits120: Co Diagnostics Inc. - Overview; Exhibits121: Co Diagnostics Inc. - Product / Service; Exhibits122: Co Diagnostics Inc. - Key news; Exhibits123: Co Diagnostics Inc. - Key offerings; Exhibits124: Danaher Corp. - Overview; Exhibits125: Danaher Corp. - Business segments; Exhibits126: Danaher Corp. - Key news; Exhibits127: Danaher Corp. - Key offerings; Exhibits128: Danaher Corp. - Segment focus; Exhibits129: Edinburgh Genetics Ltd. - Overview; Exhibits130: Edinburgh Genetics Ltd. - Product / Service; Exhibits131: Edinburgh Genetics Ltd. - Key offerings; Exhibits132: F. Hoffmann La Roche Ltd. - Overview; Exhibits133: F. Hoffmann La Roche Ltd. - Business segments; Exhibits134: F. Hoffmann La Roche Ltd. - Key news; Exhibits135: F. Hoffmann La Roche Ltd. - Key offerings; Exhibits136: F. Hoffmann La Roche Ltd. - Segment focus; Exhibits137: QIAGEN NV - Overview; Exhibits138: QIAGEN NV - Product / Service; Exhibits139: QIAGEN NV - Key news; Exhibits140: QIAGEN NV - Key offerings; Exhibits141: Thermo Fisher Scientific Inc. - Overview; Exhibits142: Thermo Fisher Scientific Inc. - Business segments; Exhibits143: Thermo Fisher Scientific Inc. - Key news; Exhibits144: Thermo Fisher Scientific Inc. - Key offerings; Exhibits145: Thermo Fisher Scientific Inc. - Segment focus; Exhibits146: ZEKMED - Overview; Exhibits147: ZEKMED - Product / Service; Exhibits148: ZEKMED - Key offerings; Exhibits149: Inclusions checklist; Exhibits150: Exclusions checklist; Exhibits151: Currency conversion rates for US$; Exhibits152: Research methodology; Exhibits153: Validation techniques employed for market sizing; Exhibits154: Information sources; Exhibits155: List of abbreviations